These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 698923)

  • 1. Binding characteristics of zearalenone analogs to estrogen receptors.
    Kiang DT; Kennedy BJ; Pathre SV; Mirocha CJ
    Cancer Res; 1978 Nov; 38(11 Pt 1):3611-5. PubMed ID: 698923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogenic activity of zearalenone and zearalanol in the neonatal rat uterus.
    Sheehan DM; Branham WS; Medlock KL; Shanmugasundaram ER
    Teratology; 1984 Jun; 29(3):383-92. PubMed ID: 6235618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear interaction of Fusarium mycotoxins with estradiol binding sites in the mouse uterus.
    Greenman DL; Mehta RG; Wittliff JL
    J Toxicol Environ Health; 1979 Jul; 5(4):593-8. PubMed ID: 490675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding properties of zearalenone mycotoxins to hepatic estrogen receptors.
    Powell-Jones W; Raeford S; Lucier GW
    Mol Pharmacol; 1981 Jul; 20(1):35-42. PubMed ID: 6457245
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA; Lippman ME; Katzenellenbogen BS
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of estrogens P-1496 and P-1560 on the binding of estradiol with rat uterine estrogen receptors.
    Di Carlo F; Conti G; Reboani C; Racca S
    Farmaco Sci; 1980 May; 35(5):425-9. PubMed ID: 7450040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the estrogenic activity of chlordecone (Kepone) in the rat: effects on uterine estrogen receptor.
    Bulger WH; Muccitelli RM; Kupfer D
    Mol Pharmacol; 1979 May; 15(3):515-24. PubMed ID: 91089
    [No Abstract]   [Full Text] [Related]  

  • 8. Dose dependent modulation of receptor dynamics and uterine growth in immature rat by estradiol: importance of an additional nuclear binding at 24 hr for long-term (72 hr) uterine growth.
    Agarwal AK; Durani S; Setty BS
    Endokrinologie; 1982 Jun; 79(2):235-41. PubMed ID: 7128542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Binding of cytosolic complexes of estradiol analogs with cell nuclei from the rabbit uterus].
    Cherniaev GA; Barkova TI; Sorokina IB; Ananchenko SN
    Biokhimiia; 1987 Feb; 52(2):225-31. PubMed ID: 3567247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of Fusarium mycotoxin action in mammary gland.
    Boyd PA; Wittliff JL
    J Toxicol Environ Health; 1978 Jan; 4(1):1-8. PubMed ID: 633402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different nuclear binding sites for antiestrogen and estrogen receptor complexes.
    Ruh TS; Baudendistel LJ
    Endocrinology; 1977 Feb; 100(2):420-6. PubMed ID: 832632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An endogenous inhibitor of [3H]estradiol binding to nuclear type II estrogen binding sites in normal and malignant tissues.
    Markaverich BM; Roberts RR; Alejandro MA; Clark JH
    Cancer Res; 1984 Apr; 44(4):1515-9. PubMed ID: 6704964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen binding sites in the nucleus of normal and malignant human tissue: characteristics of the multiple nuclear binding sites.
    Syne JS; Markaverich BM; Clark JH; Panko WB
    Cancer Res; 1982 Nov; 42(11):4449-54. PubMed ID: 7127287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Properties of alkylating derivatives of estrogens].
    Morozova TM; Merkulova TI; Martynov V; Iaguzhinskaia VP; Shkodinskaia EN
    Eksp Onkol; 1984; 6(2):50-4. PubMed ID: 6510335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extensive in situ activation of nuclear estrogen receptors after exposure of murine uteri to [3H]estradiol or [3H]4-hydroxytamoxifen.
    Pavlik EJ; Nelson K; van Nagell JR; Donaldson ES; Walden ML; Gallion H; Kenady DE
    Endocrinology; 1987 Apr; 120(4):1608-14. PubMed ID: 3830064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of cytosol and nuclear estradiol-binding sites in fetal guinea pig uterus by [3H]estradiol exchange.
    Sumida C; Pasqualini JR
    Endocrinology; 1979 Aug; 105(2):406-13. PubMed ID: 456319
    [No Abstract]   [Full Text] [Related]  

  • 17. Specific binding and biological response of antiestrogens in the fetal uterus of the guinea pig.
    Gulino A; Pasqualini JR
    Cancer Res; 1980 Oct; 40(10):3821-6. PubMed ID: 7438065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiestrogen pharmacology and mechanism of action.
    Katzenellenbogen BS; Miller MA; Eckert RL; Sudo K
    J Steroid Biochem; 1983 Jul; 19(1A):59-68. PubMed ID: 6887873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid receptor forms and their interaction with cytoplasmic modulators.
    Sato B; Nishizawa Y; Maeda Y; Noma K; Honma T; Matsumoto K
    J Steroid Biochem; 1983 Jul; 19(1A):315-21. PubMed ID: 6887866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of binding sites for tamoxifen and tamoxifen derivatives in estrogen target and nontarget fetal organs of guinea pig.
    Gulino A; Pasqualini JR
    Cancer Res; 1982 May; 42(5):1913-21. PubMed ID: 7066903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.